Vyome gets Nasdaq approval for ReShape merger, to trade as HIND Aug 13, 2025 11:50AM
Vyome names new board with MIT alumni ahead of NASDAQ listing Aug 12, 2025 09:49AM
ReShape Lifesciences Inc. (RSLS) Granted U.S. Patent Related to an Intragastric Balloon System Jul 1, 2025 08:31AM
ReShape Lifesciences Inc. (RSLS) Regains Nasdaq Compliance Jun 27, 2025 09:01AM
ReShape Lifesciences Inc. (RSLS) Announces Strategic Cost Reductions and Provides Update on the Merger Agreement with Vyome Jun 26, 2025 08:32AM


Jun 25, 2025 08:31AM ReShape Lifesciences Inc. (RSLS) Granted Key International Patent in Australia for Its Proprietary Diabetes Neuromodulation Technology
Jun 12, 2025 08:25AM ReShape Lifesciences Inc. (RSLS) Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets
Jun 9, 2025 09:02AM ReShape Lifesciences Inc. (RSLS) Prices 1.05M Share Offering at $2.50/sh
Jun 3, 2025 08:31AM ReShape Lifesciences Inc. (RSLS) Announces EU MDR Certification for Entire European and United Kingdom Product Portfolio
May 21, 2025 04:08PM ReShape Lifesciences Inc. (RSLS) Tops Q1 EPS by 1898c
May 7, 2025 08:32AM ReShape Lifesciences Inc. (RSLS) Announces 1:25 Reverse Share Split
May 2, 2025 08:31AM ReShape Lifesciences Inc. (RSLS) Presents Pre-clinical Data on Its Proprietary Diabetes Neuromodulation Device
Apr 28, 2025 08:31AM ReShape Lifesciences Inc. (RSLS) Receives Notice of Allowance for U.S. Patent Related to an Intragastric Balloon System
Apr 21, 2025 08:32AM ReShape Lifesciences Inc. (RSLS) Receives Notice of Allowance for Additional U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology
Apr 9, 2025 04:06PM ReShape Lifesciences (RSLS) Partners with Motion Informatics to Bring AI-Driven Neurorehabilitation Technology to the U.S. Market
Feb 25, 2025 08:36AM ReShape Lifesciences Inc. (RSLS) Signs Distribution Agreement in Canada With Liaison Medical for its Next-Generation Lap-Band 2.0 FLEX
Feb 3, 2025 08:31AM ReShape Lifesciences (RSLS) Granted Key International Patent in Israel
Jan 15, 2025 06:24AM ReShape Lifesciences Inc. (RSLS) Files for 2.11M Share Offering by Selling Stockholders
Jan 13, 2025 08:32AM ReShape Lifesciences Inc. (RSLS) Provides Update on Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys
Dec 20, 2024 06:31AM ReShape Lifesciences Inc. (RSLS) Files for 2.11M Share Offering by Selling Stockholders
Nov 12, 2024 08:33AM ReShape Lifesciences Inc. (RSLS) Receives Health Canada Approval for its Next-Generation Lap-Band 2.0 FLEX
Nov 11, 2024 08:32AM ReShape Lifesciences Inc. (RSLS) Receives NIH Supplementary Grant with the University of Southern California’s Center for Autonomic Nerve Recording and Stimulation Systems
Sep 19, 2024 08:34AM ReShape Lifesciences Inc. (RSLS) Announces 1-for-58 Reverse Stock Split
Aug 14, 2024 04:43PM ReShape Lifesciences Inc. (RSLS) Reports Q2 Loss of $0.06/sh
Jul 9, 2024 08:31AM ReShape Lifesciences Inc. (RSLS) to Merge with Vyome Therapeutics, Enters Asset Purchase Agreement With Biorad Medisys